On December 30, 2019, Avanos Medical, Inc. announced that, effective as of January 1, 2020, Michael C. Greiner has been appointed as Senior Vice President and Chief Financial Officer of the Company. He most recently served as executive vice president and CFO for AngioDynamics, Inc., where he played an integral role in transforming and optimizing its product portfolio through both internal development and M&A.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.12 USD | -1.15% | +4.08% | -10.21% |
05-13 | Avanos Medical, Inc. Appoints Sigfrido Delgado as Senior Vice President, Integrated Supply Chain | CI |
05-02 | Avanos Medical to Seek M&A Opportunities | CI |
1st Jan change | Capi. | |
---|---|---|
-10.21% | 878M | |
-6.65% | 180B | |
-0.73% | 109B | |
-3.28% | 68.93B | |
-4.07% | 46.41B | |
+12.73% | 45.43B | |
+7.38% | 43.26B | |
+19.21% | 30.05B | |
+16.10% | 25.19B | |
-7.38% | 23.34B |
- Stock Market
- Equities
- AVNS Stock
- News Avanos Medical, Inc.
- Avanos Medical, Inc. Announces Appointment of Michael C. Greiner as Senior Vice President and Chief Financial Officer, Effect from January 1, 2020